288 related articles for article (PubMed ID: 24069168)
21. Effect of proteasome inhibitors with different chemical structures on the ubiquitin-proteasome system in vitro.
Csizmadia V; Csizmadia E; Silverman L; Simpson C; Raczynski A; O'Brien L; Gallacher M; Cardoza K; Kadambi VJ; Fedyk ER; Alden CL
Vet Pathol; 2010 Mar; 47(2):358-67. PubMed ID: 20124009
[TBL] [Abstract][Full Text] [Related]
22. Antibody against tumor necrosis factor-α reduces bortezomib-induced allodynia in a rat model.
Chiorazzi A; Canta A; Meregalli C; Carozzi V; Sala B; Oggioni N; Monbaliu J; VAN DE Velde H; Cavaletti G
Anticancer Res; 2013 Dec; 33(12):5453-9. PubMed ID: 24324081
[TBL] [Abstract][Full Text] [Related]
23. Bortezomib induces the formation of nuclear poly(A) RNA granules enriched in Sam68 and PABPN1 in sensory ganglia neurons.
Casafont I; Berciano MT; Lafarga M
Neurotox Res; 2010 Feb; 17(2):167-78. PubMed ID: 19609631
[TBL] [Abstract][Full Text] [Related]
24. Role of satellite cell-derived L-serine in the dorsal root ganglion in paclitaxel-induced painful peripheral neuropathy.
Kiya T; Kawamata T; Namiki A; Yamakage M
Neuroscience; 2011 Feb; 174():190-9. PubMed ID: 21118710
[TBL] [Abstract][Full Text] [Related]
25. Role of a pre-existing neuropathy on the course of bortezomib-induced peripheral neurotoxicity.
Lanzani F; Mattavelli L; Frigeni B; Rossini F; Cammarota S; Petrò D; Jann S; Cavaletti G
J Peripher Nerv Syst; 2008 Dec; 13(4):267-74. PubMed ID: 19192066
[TBL] [Abstract][Full Text] [Related]
26. Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice.
Meregalli C; Carozzi VA; Sala B; Chiorazzi A; Canta A; Oggioni N; Rodriguez-Menendez V; Ballarini E; Ceresa C; Nicolini G; Crippa L; Orciani M; Cavaletti G; Marmiroli P
J Biol Regul Homeost Agents; 2015; 29(1):115-24. PubMed ID: 25864747
[TBL] [Abstract][Full Text] [Related]
27. CX3CL1-mediated macrophage activation contributed to paclitaxel-induced DRG neuronal apoptosis and painful peripheral neuropathy.
Huang ZZ; Li D; Liu CC; Cui Y; Zhu HQ; Zhang WW; Li YY; Xin WJ
Brain Behav Immun; 2014 Aug; 40():155-65. PubMed ID: 24681252
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial.
Broyl A; Corthals SL; Jongen JL; van der Holt B; Kuiper R; de Knegt Y; van Duin M; el Jarari L; Bertsch U; Lokhorst HM; Durie BG; Goldschmidt H; Sonneveld P
Lancet Oncol; 2010 Nov; 11(11):1057-65. PubMed ID: 20864405
[TBL] [Abstract][Full Text] [Related]
29. Tamoxifen suppresses paclitaxel-, vincristine-, and bortezomib-induced neuropathy via inhibition of the protein kinase C/extracellular signal-regulated kinase pathway.
Tsubaki M; Takeda T; Matsumoto M; Kato N; Yasuhara S; Koumoto YI; Imano M; Satou T; Nishida S
Tumour Biol; 2018 Oct; 40(10):1010428318808670. PubMed ID: 30360692
[TBL] [Abstract][Full Text] [Related]
30. Pathological adaptive responses of Schwann cells to endoplasmic reticulum stress in bortezomib-induced peripheral neuropathy.
Shin YK; Jang SY; Lee HK; Jung J; Suh DJ; Seo SY; Park HT
Glia; 2010 Dec; 58(16):1961-76. PubMed ID: 20830808
[TBL] [Abstract][Full Text] [Related]
31. Critical role of Ca
Tomita S; Sekiguchi F; Deguchi T; Miyazaki T; Ikeda Y; Tsubota M; Yoshida S; Nguyen HD; Okada T; Toyooka N; Kawabata A
Toxicology; 2019 Feb; 413():33-39. PubMed ID: 30552955
[TBL] [Abstract][Full Text] [Related]
32. Immune-mediated neuropathies in myeloma patients treated with bortezomib.
Ravaglia S; Corso A; Piccolo G; Lozza A; Alfonsi E; Mangiacavalli S; Varettoni M; Zappasodi P; Moglia A; Lazzarino M; Costa A
Clin Neurophysiol; 2008 Nov; 119(11):2507-12. PubMed ID: 18829381
[TBL] [Abstract][Full Text] [Related]
33. Intravenous paclitaxel administration in the rat induces a peripheral sensory neuropathy characterized by macrophage infiltration and injury to sensory neurons and their supporting cells.
Peters CM; Jimenez-Andrade JM; Jonas BM; Sevcik MA; Koewler NJ; Ghilardi JR; Wong GY; Mantyh PW
Exp Neurol; 2007 Jan; 203(1):42-54. PubMed ID: 17005179
[TBL] [Abstract][Full Text] [Related]
34. Global Transcriptomic Profile of Dorsal Root Ganglion and Physiological Correlates of Cisplatin-Induced Peripheral Neuropathy.
Lessans S; Lassiter CB; Carozzi V; Heindel P; Semperboni S; Oggioni N; Chiorazzi A; Thompson C; Wagner M; Holden J; Rahn E; Sweatt JD; Cavaletti G; Renn CL; Dorsey SG
Nurs Res; 2019; 68(2):145-155. PubMed ID: 30586060
[TBL] [Abstract][Full Text] [Related]
35. Cell-specific role of histone deacetylase 6 in chemotherapy-induced mechanical allodynia and loss of intraepidermal nerve fibers.
Ma J; Trinh RT; Mahant ID; Peng B; Matthias P; Heijnen CJ; Kavelaars A
Pain; 2019 Dec; 160(12):2877-2890. PubMed ID: 31356453
[TBL] [Abstract][Full Text] [Related]
36. Follow-up psychophysical studies in bortezomib-related chemoneuropathy patients.
Boyette-Davis JA; Cata JP; Zhang H; Driver LC; Wendelschafer-Crabb G; Kennedy WR; Dougherty PM
J Pain; 2011 Sep; 12(9):1017-24. PubMed ID: 21703938
[TBL] [Abstract][Full Text] [Related]
37. Behavioral and pharmacological characteristics of bortezomib-induced peripheral neuropathy in rats.
Yamamoto S; Kawashiri T; Higuchi H; Tsutsumi K; Ushio S; Kaname T; Shirahama M; Egashira N
J Pharmacol Sci; 2015 Sep; 129(1):43-50. PubMed ID: 26362518
[TBL] [Abstract][Full Text] [Related]
38. The antioxidant effects of the flavonoids rutin and quercetin inhibit oxaliplatin-induced chronic painful peripheral neuropathy.
Azevedo MI; Pereira AF; Nogueira RB; Rolim FE; Brito GA; Wong DV; Lima-Júnior RC; de Albuquerque Ribeiro R; Vale ML
Mol Pain; 2013 Oct; 9():53. PubMed ID: 24152430
[TBL] [Abstract][Full Text] [Related]
39. Mechanistic Involvement of Inflammation in Bortezomib-induced Peripheral Neuropathy.
Goel L; Gupta P; Pahuja M
Comb Chem High Throughput Screen; 2022; 25(10):1595-1600. PubMed ID: 35611787
[TBL] [Abstract][Full Text] [Related]
40. Inflammatory autoimmune neuropathy, presumably induced by bortezomib, in a patient suffering from multiple myeloma.
Schmitt S; Goldschmidt H; Storch-Hagenlocher B; Pham M; Fingerle-Rowson G; Ho AD; Neben K
Int J Hematol; 2011 Jun; 93(6):791-794. PubMed ID: 21553020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
